Skin Cancer

Official Title: Randomized Phase III Trial of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma 

Study Purpose: To test if giving immunotherapy before and after (in some cases) surgery extend the length of time without your cancer returning compared to the usual approach 

Status: Suspended